Search Results - "Hodgetts, SI"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Strain-specific differences in the effects of cyclosporin A and FK506 on the survival and regeneration of axotomized retinal ganglion cells in adult rats by Cui, Q, Hodgetts, S.I, Hu, Y, Luo, J.-M, Harvey, A.R

    Published in Neuroscience (25-05-2007)
    “…Abstract The immune response can influence neuronal viability and plasticity after injury, effects differing in strains of rats with different susceptibility…”
    Get full text
    Journal Article
  2. 2

    Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells by Hodgetts, S I, Beilharz, M W, Scalzo, A A, Grounds, M D

    Published in Cell transplantation (01-07-2000)
    “…Overcoming the massive and rapid death of injected donor myoblasts is the primary hurdle for successful myoblast transfer therapy (MTT), designed as a…”
    Get full text
    Journal Article
  3. 3

    Irradiation of dystrophic host tissue prior to myoblast transfer therapy enhances initial (but not long-term) survival of donor myoblasts by Hodgetts, Stuart I, Grounds, Miranda D

    Published in Journal of cell science (15-10-2003)
    “…There is a massive and rapid death of donor myoblasts (<20% surviving) within hours after intramuscular injection in myoblast transfer therapy (MTT), due to…”
    Get full text
    Journal Article
  4. 4

    Problems and solutions in myoblast transfer therapy by Smythe, Gayle M., Hodgetts, Stuart I., Grounds, Miranda D.

    Published in Journal of cellular and molecular medicine (01-01-2001)
    “…Duchenne muscular dystrophy is a severe X‐linked neuromuscular disease that affects approximately 1/3500 live male births in every human population, and is…”
    Get full text
    Journal Article
  5. 5

    A role for natural killer cells in the rapid death of cultured donor myoblasts after transplantation by HODGETTS, Stuart I, SPENCER, Melissa J, GROUNDS, Miranda D

    Published in Transplantation (27-03-2003)
    “…The rapid and massive death of cultured donor myoblasts after injection in vivo is a major problem for clinical myoblast transfer therapy (MTT). This study…”
    Get full text
    Journal Article
  6. 6

    Immunobiology and the Future of Myoblast Transfer Therapy by Smythe, Gayle M., Hodgetts, Stuart I., Grounds, Miranda D.

    Published in Molecular therapy (01-04-2000)
    “…Myoblast transfer therapy (MTT) is a cell-mediated gene transfer method aimed at the restoration of normal dystrophin expression in Duchenne muscular dystrophy…”
    Get full text
    Journal Article
  7. 7

    Characterization of Defective Viral RNA Produced during Persistent Infection of Vero Cells with Murray Valley Encephalitis Virus by Lancaster, M U, Hodgetts, S I, Mackenzie, J S, Urosevic, N

    Published in Journal of Virology (01-03-1998)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  8. 8

    Complement and myoblast transfer therapy: Donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5 by Hodgetts, Stuart I, Grounds, Miranda D

    Published in Immunology and cell biology (01-06-2001)
    “…Myoblast transfer therapy (MTT) is a potential cell therapy for myopathies such as Duchenne Muscular Dystrophy and involves the injection of cultured muscle…”
    Get full text
    Journal Article
  9. 9

    A comparison between real-time quantitative PCR and DNA hybridization for quantitation of male DNA following myoblast transplantation by Bosio, Erika, Lee-Pullen, Tracey F, Fragall, Clayton T, Beilharz, Manfred W, Bennett, Alayne L, Grounds, Miranda D, Hodgetts, Stuart I, Sammels, Leanne M

    Published in Cell transplantation (01-01-2004)
    “…The transplantation of muscle precursor cells (myoblasts) is a potential therapy for Duchenne muscular dystrophy. A commonly used method to detect cell…”
    Get full text
    Journal Article
  10. 10

    Development and characterization of new flavivirus-resistant mouse strains bearing Flv(r)-like and Flv(mr) alleles from wild or wild- derived mice by Urosevic, N, Silvia, OJ, Sangster, MY, Mansfield, JP, Hodgetts, SI, Shellam, GR

    Published in Journal of general virology (01-04-1999)
    “…N Urosevic, OJ Silvia, MY Sangster, JP Mansfield, SI Hodgetts and GR Shellam Department of Microbiology, University of Western Australia, Nedlands, Australia…”
    Get full text
    Journal Article
  11. 11

    Development and characterization of new flavivirus-resistant mouse strains bearing Flv super(r)-like and Flv super(mr) alleles from wild or wild-derived mice by Urosevic, N, Silvia, O J, Sangster, MY, Mansfield, J P, Hodgetts, SI, Shellam, G R

    Published in Journal of general virology (01-04-1999)
    “…A single genetic locus, flavivirus resistance (Flv), controls virus titres and severity of flavivirus infection in mouse brain. It has been mapped to mouse…”
    Get full text
    Journal Article
  12. 12

    Differential transcription efficiency of two Ig VH promoters in vitro by Buchanan, KL, Hodgetts, SI, Byrnes, J, Webb, CF

    Published in The Journal of immunology (1950) (01-11-1995)
    “…Each Ig variable region gene segment is transcribed from its own unique promoter. While all of these promoters share common consensus elements that contribute…”
    Get full text
    Journal Article
  13. 13

    Differential transcription efficiency of two Ig V sub(H) promoters in vitro by Buchanan, K L, Hodgetts, SI, Byrnes, J, Webb, C F

    Published in The Journal of immunology (1950) (01-01-1995)
    “…Each Ig variable region gene segment is transcribed from its own unique promoter. While all of these promoters share common consensus elements that contribute…”
    Get full text
    Journal Article